174 related articles for article (PubMed ID: 3488202)
1. Direct and indirect pathogenicity of Branhamella catarrhalis.
Brook I
Drugs; 1986; 31 Suppl 3():97-102. PubMed ID: 3488202
[TBL] [Abstract][Full Text] [Related]
2. Branhamella catarrhalis--an emerging human pathogen.
Doern GV
Diagn Microbiol Infect Dis; 1986 Mar; 4(3):191-201. PubMed ID: 3514103
[No Abstract] [Full Text] [Related]
3. The occurrence of Branhamella catarrhalis and other commensal Neisseriaceae in clinical sputum specimens in Lagos, Nigeria.
Obi MC; Animashaun T; Odugbemi T
Eur J Epidemiol; 1990 Sep; 6(3):323-5. PubMed ID: 2123801
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands.
Davies BI; Maesen FP
Drugs; 1986; 31 Suppl 3():28-33. PubMed ID: 3488195
[TBL] [Abstract][Full Text] [Related]
5. The role of beta-lactamase-producing bacteria in respiratory tract infections.
Brook I
Scand J Infect Dis Suppl; 1988; 57():41-9. PubMed ID: 3074471
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect pathogenicity of anaerobic bacteria in respiratory tract infections in children.
Brook I
Adv Pediatr; 1987; 34():357-77. PubMed ID: 3318301
[TBL] [Abstract][Full Text] [Related]
7. A 2-year survey of Branhamella catarrhalis in a general hospital.
Smith JM; Lockwood BM
J Hosp Infect; 1986 May; 7(3):277-82. PubMed ID: 2873174
[TBL] [Abstract][Full Text] [Related]
8. Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
Eliasson I; Kamme C
Drugs; 1986; 31 Suppl 3():116-21. PubMed ID: 3488190
[TBL] [Abstract][Full Text] [Related]
9. [Respiratory tract infection with Branhamella catarrhalis].
Matsumoto K; Nagatake T; Uzuka Y; Rikitomi N; Noguchi Y
Nihon Naika Gakkai Zasshi; 1982 Dec; 71(12):1696-702. PubMed ID: 6984859
[No Abstract] [Full Text] [Related]
10. The concept of indirect pathogenicity by beta-lactamase production, especially in ear, nose and throat infection.
Brook I
J Antimicrob Chemother; 1989 Nov; 24 Suppl B():63-72. PubMed ID: 2691486
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
Alvarez S; Jones M; Holtsclaw-Berk S; Guarderas J; Berk SL
Antimicrob Agents Chemother; 1985 Apr; 27(4):646-7. PubMed ID: 3873905
[TBL] [Abstract][Full Text] [Related]
12. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
Roth RM; Gleckman RA; Hibert DM
Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
[TBL] [Abstract][Full Text] [Related]
13. Branhamella catarrhalis as an indirect pathogen.
Wardle JK
Drugs; 1986; 31 Suppl 3():93-6. PubMed ID: 3732085
[TBL] [Abstract][Full Text] [Related]
14. Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
Nash DR; Wallace RJ; Steingrube VA; Shurin PA
Drugs; 1986; 31 Suppl 3():48-54. PubMed ID: 3488197
[TBL] [Abstract][Full Text] [Related]
15. [Branhamella catarrhalis in infectious pathology of the respiratory tract].
Le Faou A; Rio A
Presse Med; 1983 Sep; 12(33):2035-7. PubMed ID: 6226017
[TBL] [Abstract][Full Text] [Related]
16. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.
Thornley PE; Aitken JM; Nichol GM; Slevin NJ
Drugs; 1986; 31 Suppl 3():113-4. PubMed ID: 3525087
[TBL] [Abstract][Full Text] [Related]
17. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.
Saito A; Yamaguchi K; Shigeno Y; Kohno S; Shigeno H; Kusano N; Dotsu Y; Hara K
Drugs; 1986; 31 Suppl 3():87-92. PubMed ID: 3488201
[TBL] [Abstract][Full Text] [Related]
18. Role of anaerobic beta-lactamase-producing bacteria in upper respiratory tract infections.
Brook I
Pediatr Infect Dis J; 1987 Mar; 6(3):310-6. PubMed ID: 3554127
[TBL] [Abstract][Full Text] [Related]
19. Bronchopulmonary infection due to Branhamella catarrhalis.
McLeod DT; Ahmad F; Power JT; Calder MA; Seaton A
Br Med J (Clin Res Ed); 1983 Nov; 287(6403):1446-7. PubMed ID: 6416451
[TBL] [Abstract][Full Text] [Related]
20. Direct and indirect pathogenicity of beta-lactamase-producing bacteria in respiratory tract infection in children. Role of cephalosporins resistant to enzymatic hydrolysis.
Stefani S; Pellegrino MB; Russo G; Nicoletti G
Drugs; 1991; 42 Suppl 4():14-8. PubMed ID: 1725149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
